UMnyango Wezizwe Zonke

Emkhakheni womhlaba wonke wokuxilongwa nokwelashwa komdlavuza wamaphaphu, ukutholwa kusenesikhathi kanye nokwelashwa okunembile kwamaqhubu emaphaphu bekulokhu kugxilwe kakhulu kwezokwelapha. Njengezithunzi eziqinile ezigxile ekuthathweni kwezithombe zamaphaphu, amaqhubu emaphaphu ayahlukahluka ngokwemvelo, kusukela ekuvuvukeni okungenabungozi kuya ekuguleni kwasekuqaleni...Funda kabanzi»

Ohambweni lokulwa nomdlavuza, umphakathi wezokwelapha ubulokhu ufuna izindlela zokwelapha ezisebenza kahle neziphephile. Nakuba ukuhlinzwa, ukwelashwa ngemisebe, ukwelashwa ngamakhemikhali, kanye nokwelashwa nge-biotherapy kuye kwabeka isisekelo esiqinile sokwelashwa komdlavuza, i-hyperthermia—ubuchwepheshe besimanje obuvela ekuhlakanipheni kwasendulo—...Funda kabanzi»

Njengoba bebhekene nokuxilongwa komdlavuza, ithemba elihlanganyelwe leziguli emhlabeni wonke ukuthola inketho yokwelapha ephumelela kakhulu, ethuthukisiwe, futhi engangenisi kakhulu. Uma ufuna isibhedlela esihlanganisa ubuchwepheshe bezokwelapha baseShayina obusezingeni eliphezulu, ubuchwepheshe obusezingeni eliphezulu, kanye nezinsizakalo ezijwayelekile zomhlaba wonke,...Funda kabanzi»

Uma wena noma othandekayo wakho ebhekene nokuxilongwa komdlavuza futhi uzizwa ulinganiselwe noma ungenathemba ngenkathi ufuna izindlela zokwelapha endaweni yakini, ingabe uke uzibuze: Ngakolunye uhlangothi lomhlaba, ingabe kunezindlela zokwelapha ezithuthukisiwe kakhulu, ezingangeni kakhulu, nezinethemba kakhulu ezitholakalayo? Ukuze uthole imibuzo mayelana nokwelashwa okusha komdlavuza...Funda kabanzi»

Isiguli esinesifo somdlavuza wobuchopho esibulalayo, esasiphinde sabuyela esimweni saso ngemva kokwelashwa kwe-CAR-T izikhathi ezingu-17, sabona isimila saso sinyamalala ngokuphelele zingakapheli amasonto amane sithole ukwelashwa okusha kwe-TIL futhi sihlale singenaso isimila izinyanga ezingaphezu kuka-20. Ukuze uthole imibuzo mayelana nokwelashwa okusha komdlavuza kanye nezivivinyo zemitholampilo: Ucingo: 4008803716 | WeChat:...Funda kabanzi»

Ngomhlaka-17 Novemba 2025, u-Abbisko wamemezela isethulo sephosta sokusebenza kahle kwesikhathi eside, ukuphepha kanye nemiphumela ebikwe yiziguli evela ocwaningweni lomhlaba wonke lweSigaba III se-MANEUVER se-pimicotinib (ABSK021) ezigulini ezine-tenosynovial giant cell tumor (TGCT) e-Connective Tissue Oncology Society (CTOS) 2025 ...Funda kabanzi»

8 Septhemba 2025, i-InnoCare Pharma imemezele ukuthi i-HIBRUKA (orelabrutinib) ivunyelwe yi-Health Sciences Authority (HSA) yaseSingapore ekwelapheni iziguli ezindala ezine-relapse noma refractory marginal zone lymphoma (R/R MZL). Okwamanje, kusenezivivinyo eziningi zemitholampilo ze-an...Funda kabanzi»

Ngomhlaka-28 Agasti, i-Center for Drug Evaluation (CDE) ye-National Medical Products Administration (NMPA) yamemezela ukuthi i-BL-B01D1 yomjovo ihlongozwa ukuthi ifakwe enkambisweni yokubuyekezwa okubalulekile. Yenzelwe iziguli ezine-carcinoma ye-nasopharyngeal ephindaphindayo noma esakazeke kakhulu ezinesifo sangaphambi...Funda kabanzi»

Ngomhlaka-21 Agasti, i-bispecific T cell engager, i-epcoritamab, inikezwe ukubuyekezwa okubalulekile yi-Center for Drug Evaluation (CDE) ye-National Medical Products Administration (NMPA). Ukuvunyelwa kuqondiswe ezigulini ezindala ezine-relapse or refractory follicular lymphoma (FL), okuyisigaba esidinga kakhulu...Funda kabanzi»

Ngomhlaka-29 kuNcwaba, i-HERNEXEOS® kaBoehringer Ingelheim (amaphilisi e-zongertinib) avunyelwe njengokwelashwa okukodwa yi-National Medical Products Administration (NMPA) yaseShayina yokwelapha iziguli ezindala ezinomdlavuza wamaphaphu ongewona amaseli amancane (i-NSCLC) ongasuswa, othuthuke endaweni noma osakazeke kakhulu onezimila ...Funda kabanzi»

Ngomhlaka-22 Agasti 2025, i-Datopotamab deruxtecan (Dato-DXd; Datroway) ithole imvume eShayina yokwelapha iziguli ezindala ezine-receptor ye-hormone engasuswa noma ene-metastatic, i-HER2-negative (immunohistochemistry [IHC] 0, IHC 1+, noma i-IHC 2+/in situ hybridization [ISH] negative) yebele...Funda kabanzi»

Ngo-Agasti 2025, i-Center for Drug Evaluation (CDE) ye-National Medical Products Administration (NMPA) yanikeza ngokusemthethweni i-Breakthrough Therapy Designation ku-Ina-cel, ukwelashwa okusha kweseli le-CAR-T okuqondiswa yi-CD19 okwakhiwe ngokuzimela yi-Juventas, ukuze kuphathwe iziguli zezingane ezine-re...Funda kabanzi»